Pharmacokinetics of a New Once-Daily Controlled-Release Formulation of Aceclofenac in Korean Healthy Subjects Compared with Immediate-Release Aceclofenac and the Effect of Food: A Randomized, Open-Label, Three-Period, Crossover, Single-Centre Study

Author： >  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.2, 2012-02, pp. : 111-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young Adults: A Randomized, Open-Label, Two-Period Crossover, Single-Centre Study

By Darwish Mona   Hellriegel Edward T.   Xie Fang  

Clinical Drug Investigation, Vol. 28, Iss. 12, 2008-01 ,pp. : 793-801

Adis International

Access to resources Recommend Favorite

Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg: A Randomized, Open-Label, Crossover, Single-Centre Study

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 145-152

Adis International

Access to resources Recommend Favorite

Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the Elderly: A Randomized, Open-Label, Crossover Study

By Darwish Mona  

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 95-101

Adis International

Access to resources Recommend Favorite

Dosage Form Proportionality and Food Effect of the Final Tablet Formulation of Eslicarbazepine Acetate: Randomized, Open-Label, Crossover, Single-Centre Study in Healthy Volunteers

By Fontes-Ribeiro Carlos  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 447-454

Adis International

Access to resources Recommend Favorite

Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects: A Phase I, Open-Label, Three-Period, Crossover Study

By Finn Andrew L.  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite